Organizational Performance Management Table Essay

After you have completed your individual research on your chosen type of health care organization, collaborate with your Learning Team to complete this table. Then, refer to this table as you collaborate to write your paper. Include this table as an appendix to your paper. Fill in the necessary information in each cell, but be as succinct as possible. 1. Provide names of or links to specific organizations. Summarize key products or services provided by each type of organization and identify the primary customers they serve. Organization One Organization Two Organization Three http://www.fda.gov/ U.S. Food and Drug Administration 2. Outline the overall content of the major regulations, accreditation requirements, and other standards that affect each organization. Provide the title, section, parts, or subparts or the numbering system and so on of the specific regulations or accreditation requirements. For example: Use of electronic signatures in electronic medical records is equivalent to handwritten signatures on paper; FDA regulation; Title 21 CFR Part 11, Subpart C, Â § 11.200 Electronic Signature: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpart=11 Organization One Organization Two Organization Three Food and Drug Administration Safety and Innovation Act (FDASIA) Because of their importance, an agency’s rulemaking plans are of great interest to a wide range to stakeholders. Therefore, the Federal Government publishes a semi-annual agenda of upcoming regulations in the Federal Register, usually in the Spring and Fall. As part of FDA’s Transparency Initiative and FDA Transparency Results Accountability Credibility Knowledge Sharing (TRACK), we are also providing periodic updates on FDA’s Unified Agenda rulemakings. On the Unified Agenda-TRACK Web page, we will maintain an updated agenda of FDA’s Unified Agenda rulemakings. 3. Highlight the effect of each organization’s regulations, accreditation requirements, and other standards on the risk- and quality-management functions and activities. Organization One Organization Two Organization Three The scope of FDA’s regulatory authority is very broad. FDA’s responsibilities are closely related to those of several other government agencies. Often frustrating and confusing for consumers is determining the appropriate regulatory agency to contact. The following is a list of traditionally-recognized product categories that fall under FDA’s regulatory jurisdiction; however, this is not an exhaustive list. In general, FDA regulates: Foods, including: dietary supplements bottled water food additives infant formulas other food products (although the U.S. Department of Agriculture plays a lead role in regulating aspects of some meat, poultry, and egg products) Drugs, including: prescription drugs (both brand-name and generic) non-prescription (over-the-counter) drugs Biologics, including: vaccines blood and blood products cellular and gene therapy products tissue and tissue products allergenics Medical Devices, including: simple items like tongue depressors and bedpans complex technologies such as heart pacemakers dental devices surgical implants and prosthetics Electronic Products that give off radiation, including: microwave ovens x-ray equipment laser products ultrasonic therapy equipment mercury vapor lamps sunlamps Cosmetics, including: color additives found in makeup and other personal care products skin moisturizers and cleansers nail polish and perfume Veterinary Products, including: livestock feeds pet foods veterinary drugs and devices Tobacco Products, including: cigarettes cigarette tobacco roll-your-own tobacco smokeless tobacco 4. Specify components of performance-management systems—policies and procedures, self-audits, benchmarking, complaint management, corrective or preventive action, education and training, communication, and other mechanisms—to be used by each organization. Organization One Organization Two Organization Three Risk communication staff: Our Risk Communication Staff’s objective is to assess and enhance FDA’s approaches to effectively communicate the risks and benefits of using FDA-regulated products. This includes providing leadership in identifying, developing, conducting and promoting cross-cutting research, promoting understandable communication, and finding ways to improve the consistency and effectiveness of our communication approaches. This program also directs the activities of FDA’s Risk Communication Advisory Committee, which was established: to advise on strategies and programs to communicate the risks and benefits of FDA-regulated products so as to facilitate optimal use; to review and evaluate FDA’s and others’ research relevant to such communication; and to facilitate interactively sharing risk and benefit information with the public to help people make informed independent judgments about use of FDA-regulated products. Our major functions include: Coordinating development of agency policies on risk communication practices. Coordinating agency strategic planning activities concerning risk communications. Coordinating agency research agenda for risk communication methods. Facilitating development and sharing of risk communication best practices and standard operating procedures. Conducting risk communications research on methodological and cross-cutting issues. Leading management and coordination of the FDA Risk Communication Advisory Committee. Staffing and co-leading FDA’s Communications Council 5. Provide links to any relevant sources that will be useful as your Learning Team completes the paper. Organization One Organization Two Organization Three Fda.gov